Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for North Shore University Hospital located at 300 Community Drive, Manhasset, NY, 11030 & includes data from NPIs 1952317711, 1366459570, 1295742468
Dexur analyzed Q2 2017 (April to June 2017) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for North Shore University Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Apr 2017 to Jun 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 4,124 | 3,869 | ||||||||||
Surgical | 1,256 | 1,212 | ||||||||||
Non Surgical | 2,868 | 2,657 | ||||||||||
Cardiovascular | 966 | 920 | ||||||||||
General Medicine | 677 | 602 | ||||||||||
Orthopedics | 528 | 517 | ||||||||||
Gastroenterology & Endocrinology | 396 | 381 | ||||||||||
Pulmonology | 321 | 303 | ||||||||||
General Surgery | 292 | 268 | ||||||||||
Urology | 283 | 272 | ||||||||||
Neurology | 239 | 211 | ||||||||||
Oncology & Hematology | 186 | 164 | ||||||||||
Spine | 75 | 75 | ||||||||||
Colorectal | 68 | 66 | ||||||||||
Psychiatry & Mental Disorders | 38 | 37 | ||||||||||
Dermatology | 20 | 20 | ||||||||||
Obesity, Bariatric, Stomach & Duodenal | 18 | 17 | ||||||||||
Obstetrics & Gynecology | 17 | 16 |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Apr 2017 to Jun 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Heart Failure And Shock | ||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 293: HEART FAILURE AND SHOCK WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Syncope And Collapse | ||||||||||||
DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 220: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Coronary Bypass | ||||||||||||
DRG 234: CORONARY BYPASS WITH CARDIAC CATHETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 236: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Chest Pain | ||||||||||||
DRG 313: CHEST PAIN | ||||||||||||
Endovascular Procedures | ||||||||||||
DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Permanent Cardiac Pacemaker Implant | ||||||||||||
DRG 244: PERMANENT CARDIAC PACEMAKER IMPLANT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 243: PERMANENT CARDIAC PACEMAKER IMPLANT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Acute Myocardial Infarction | ||||||||||||
DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Vascular Procedures | ||||||||||||
DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 253: OTHER VASCULAR PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Circulatory System Diagnoses | ||||||||||||
DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 315: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Peripheral Vascular Disorders | ||||||||||||
DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Percutaneous Intracardiac Procedures | ||||||||||||
DRG 274: PERCUTANEOUS INTRACARDIAC PROCEDURES W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Hypertension | ||||||||||||
DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cardiac Congenital And Valvular Disorders | ||||||||||||
Other Major Cardiovascular Procedures |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Apr 2017 to Jun 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 870: SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | ||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cellulitis | ||||||||||||
DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Signs And Symptoms | ||||||||||||
DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Complications Of Treatment | ||||||||||||
Poisoning And Toxic Effects Of Drugs | ||||||||||||
DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Postoperative And Post-Traumatic Infections | ||||||||||||
Otitis Media And Upper Respiratory Infection | ||||||||||||
Fever And Inflammatory Conditions | ||||||||||||
DRG 864: FEVER |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Apr 2017 to Jun 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 469: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||
DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 482: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Medical Back Problems | ||||||||||||
DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Fractures Of Hip And Pelvis | ||||||||||||
DRG 536: FRACTURES OF HIP AND PELVIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy | ||||||||||||
Fracture, Sprain, Strain And Dislocation Except Femur, Hip, Pelvis And Thigh | ||||||||||||
DRG 563: FRACTURE SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Lower Extremity And Humerus Procedures Except Hip,Foot,Femur | ||||||||||||
Signs And Symptoms Of Musculoskeletal System And Connective Tissue | ||||||||||||
DRG 556: SIGNS AND SYMPTOMS OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Musculoskeletal System And Connective Tissue O.R. Procedures | ||||||||||||
Amputation Of Lower Limb For Endocrine, Nutritional And Metabolic Disorders | ||||||||||||
Bone Diseases And Arthropathies |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Apr 2017 to Jun 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
G.I.Hemorrhage | ||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 379: G.I. HEMORRHAGE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Digestive System Diagnoses | ||||||||||||
DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Diabetes | ||||||||||||
DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
G.I. Obstruction | ||||||||||||
Disorders Of Biliary Tract | ||||||||||||
Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
DRG 372: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Cholecystectomy | ||||||||||||
Endocrine Disorders |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Apr 2017 to Jun 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Chronic Obstructive Pulmonary Disease | ||||||||||||
DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Simple Pneumonia And Pleurisy | ||||||||||||
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Respiratory Infections And Inflammations | ||||||||||||
DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Bronchitis And Asthma | ||||||||||||
DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Respiratory System Diagnosis With Ventilator Support | ||||||||||||
DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||
Pulmonary Embolism | ||||||||||||
DRG 176: PULMONARY EMBOLISM WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Pulmonary Edema And Respiratory Failure | ||||||||||||
DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
Major Chest Trauma | ||||||||||||
Respiratory Signs And Symptoms | ||||||||||||
DRG 204: RESPIRATORY SIGNS AND SYMPTOMS |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Apr 2017 to Jun 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Craniotomy And Endovascular Intracranial Procedures | ||||||||||||
DRG 025: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 026: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Peripheral And Cranial Nerve And Other Nervous System Procedures | ||||||||||||
Other Respiratory System O.R. Procedures | ||||||||||||
Non-Extensive Procedure Unrelated To Principal Diagnosis | ||||||||||||
Extracranial Procedures | ||||||||||||
Peritoneal Adhesiolysis | ||||||||||||
Other Skin, Subcutaneous Tissue And Breast Procedures | ||||||||||||
Postoperative Or Post-Traumatic Infections With O.R. Procedure | ||||||||||||
Hernia Procedures |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Apr 2017 to Jun 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Kidney And Urinary Tract Infections | ||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Renal Failure | ||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Kidney And Urinary Tract Diagnoses | ||||||||||||
DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Kidney And Ureter Procedures |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Apr 2017 to Jun 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
Degenerative Nervous System Disorders | ||||||||||||
DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Traumatic Stupor And Coma, Coma < 1 Hour | ||||||||||||
Cranial And Peripheral Nerve Disorders | ||||||||||||
Other Disorders Of Nervous System | ||||||||||||
Seizures | ||||||||||||
Traumatic Stupor And Coma, Coma > 1 Hour | ||||||||||||
Transient Ischemia | ||||||||||||
DRG 069: TRANSIENT ISCHEMIA |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Apr 2017 to Jun 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Red Blood Cell Disorders | ||||||||||||
DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||
DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Lymphoma And Non-Acute Leukemia | ||||||||||||
DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Digestive Malignancy | ||||||||||||
Malignancy Of Hepatobiliary System Or Pancreas | ||||||||||||
Respiratory Neoplasms | ||||||||||||
Nervous System Neoplasms | ||||||||||||
Coagulation Disorders | ||||||||||||
DRG 813: COAGULATION DISORDERS |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Apr 2017 to Jun 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Spinal Fusion Except Cervical | ||||||||||||
DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cervical Spinal Fusion | ||||||||||||
DRG 472: CERVICAL SPINAL FUSION WITH COMPLICATION OR COMORBIDITY (CC) |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Apr 2017 to Jun 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures | ||||||||||||
DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Apr 2017 to Jun 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychoses | ||||||||||||
DRG 885: PSYCHOSES | ||||||||||||
Organic Disturbances And Intellectual Disability | ||||||||||||
DRG 884: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Apr 2017 to Jun 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Trauma To The Skin, Subcutaneous Tissue And Breast |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Apr 2017 to Jun 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Stomach, Esophageal And Duodenal Procedures |